Toronto, Ontario–(Newsfile Corp. – December 5, 2023) – Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), developer and partner in a wide-range of leading-edge, proprietary diagnostic and medical device technologies, announces that a cease trade order has been issued by the Ontario Securities Commission for not filing the following documents by the periodic disclosure deadline:
The Company would like to inform shareholders that it is working diligently with its new auditor to file the above documents as soon as they are finalized. The Company does not anticipate a lengthy delay in filing the required documents. Once the documents are filed the Company will request an application to revoke the cease trade order.
About Therma Bright Inc.
Therma Bright is a developer and partner in a wide range of leading edge, proprietary diagnostic and medical device technologies focused on providing consumers and medical professionals with quality, innovative solutions that address some of today’s most important medical and healthcare challenges. Therma Bright Inc. trades on the (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX). Visit: www.thermabright.com.
Therma Bright Inc.
Rob Fia, CEO
rfia@thermabright.com
Follow us on Twitter
FORWARD-LOOKING STATEMENTS
Certain statements in this news release constitute “forward-looking” statements. These statements relate to future events such as the commercialization of DCA and related technology as described in the news release. All such statements involve substantial known and unknown risks, uncertainties and other factors which may cause the actual results to vary from those expressed or implied by such forward-looking statements. Forward-looking statements involve significant risks and uncertainties, they should not be read as guarantees of future performance or results, and they will not necessarily be accurate indications of whether such results will be achieved. Actual results could differ materially from those anticipated due to several factors and risks. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions on the date of this news release, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any forward-looking statements whether because of new information, future events or otherwise, except as required under applicable securities regulations.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/189884
Toronto, Ontario--(Newsfile Corp. - June 18, 2024) - Empatho Holdings Inc. (the "Company") announces that…
WASHINGTON, DC / ACCESSWIRE / June 18, 2024 / Patients for Patient Safety US (PFPS…
Makers of the sam® wearable ultrasound unit present new research on the effectiveness of sustained…
Child care in the Veterinary IndustryBEND, OR / ACCESSWIRE / June 18, 2024 / Vet…
Dublin, Ireland--(Newsfile Corp. - June 18, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43)…
Investment to fund acquisitions of three operating healthcare facilities in Texas, Ohio and Connecticut, totaling…